The trajectory of Viagra presents a challenging picture for investors. While the initial launch generated significant profits, the end of its exclusive rights opened the avenue to generic alternatives, dramatically https://bookmarkbells.com/story21713563/sildenafil-and-pharma-a-risky-opportunity